Health Disclaimer Shotsy is not a medical device and does not diagnose, treat, cure, or prevent any medical condition
Document what was assessed, what clinical decision was made, and how that decision differed from the injection administration work
This indicates that GLP-1 is involved in the formation of constipation, but the underlying mechanism remains unclear
Topical GHK-Cu is a cosmetic ingredient that may support skin appearance with minimal downtime Microneedling may lead to more noticeable visual changes but requires recovery time and professional care The two methods may complement each other, as microneedling can enhance the absorption of topical products GHK-Cu is not a drug
Moreover, GLP-1 receptor agonist use was also associated with significantly lower cartilage-loss velocity in the medial femorotibial joint (adjusted mean difference, 0.02 mm
Will side effects return with dose increases Some patients experience temporary symptoms after dose increases, which usually resolve within one to two weeks